Inflammatory mediators in the development and progression of benign prostatic hyperplasia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/nrurol.2016.168.pdf
Reference104 articles.
1. Kramer, G., Mitteregger, D. & Marberger, M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur. Urol. 51, 1202–1216 (2007).
2. Robert, G., Descazeaud, A., Allory, Y., Vacherot, F. & de la Taille, A. Should we investigate prostatic inflammation for the management of benign prostatic hyperplasia? Eur. Urol. Suppl. 8, 879–886 (2009).
3. Sciarra, A. et al. Inflammation and chronic prostatic diseases: evidence for a link? Eur. Urol. 52, 964–972 (2007).
4. De Nunzio, C., Albisinni, S., Gacci, M. & Tubaro, A. The role of inflammation in the progression of benign prostatic hyperplasia. Curr. Bladder Dysfunct. Rep. 8, 142–149 (2013).
5. Tubaro, A., De Nunzio, C., Puccini, F. & Presicce, F. The evolving picture of lower urinary tract symptom management. Eur. Urol. 67, 271–272 (2015).
Cited by 146 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS);The Prostate;2024-01-09
2. Increased Risk of Benign Prostate Hyperplasia (BPH) in Patients with Gout: A Longitudinal Follow-Up Study Using a National Health Screening Cohort;Diagnostics;2023-12-26
3. Mechanisms Research on Benign Prostatic Hyperplasia Intervened by Tong Guan Pill Based on Label Free Proteomics;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05
4. Shuangshi Tonglin Capsule treats benign prostatic hyperplasia through the ROS/NLRP3 signaling pathway;International Urology and Nephrology;2023-12-01
5. Unveiling prostatic inflammation to optimize management of lower urinary tract symptoms: a discussion with experts;Biomarkers in Medicine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3